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Immunohistochemical analysis was carried out to examine infiltration 
of lymphocytes in the tumor nests of nasopharyngeal carcinoma 
(NPC) using 38 biopsy cases obtained from southern China. These 
cases were divided into 3 groups according to their prominent pattern 
associated with the cell and the tissue differentiation using the World 
Health Organaization (WHO) classification as follows: (i) 6 cases of 
squamous cell carcinoma (16%), (ii) 25 cases of differentiated 
non-keratinizing carcinoma (66%), (ii) 7 cases of undifferentiated 
carcinoma (18%). All tumor tissues reacted diffusely with MB-1, 
however, these did not react with L26 (CD20), 4KB5 (CD45R), MT-1, 
and leukocyte common antigen (LCA). In the tumor nests, normal 
lymphocytes were observed in squamous cell carcinoma type (50%), 
differentiated non-keratinizing carcinoma type (72%), and 
undifferentiated carcinoma type (86%). Therefore, it is suggested that 
a large number of infiltrating non-neoplastic T-cells may be related to 
good prognosis. T-cell-rich B-cell lymphomas (TCRBCLs) are 
recently described as unusual non-Hodgkin's lymphomas associated 
with predominance of reactive T-cells. Therefore, the mechanism of 
T-cell lymphocyte infiltration adjacent to the tumor cell is considered 
that these T-cell infiltrates may be the passive response to cytokine 
secretion by the tumor cells.
Introduction 
Nasopharyngeal carcinoma (NPC) was first described as a 
neoplasm occurring in the nasopharynx, characterized by 
anaplastic cells surrounded by prominent infiltration of 
lymphoid cells. This tumor has been known as lymphoepi-
thelioma. The nuclear features of the carcinoma cells are 
distinctive with large nucleus and prominent nucleolus. The 
cytoplasmic features of the carcinoma cells are variable 
and the cellular borders are often indistinct due to fusion of 
cytoplasms. NPC has been confirmed as arising from squa-
mous epithelium by electron microscopical and immuno-
histochemical examination. According to the World Health 
Organaization (WHO) classification, NPC was divided into 
three types; squamous cell carcinoma, differentiated non-
keratinizing carcinoma, and undifferentiated carcinoma."' 
Lymphoepithelioma occurs outside of the nasopharynx,
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although generally they are rare lesions. Histologically 
similar undifferentiated carcinoma associated with marked 
lymphoid cell infiltration is called lymphoepithelioma-like 
carcinoma which has been found in the tonsil,') salivary 
gland,""' thymus,") uterine cervix,'' skin,"' lung," and 
stomach. 14' 
 Normal small lymphocytes are frequently observed in 
tissue sections. They are often found in follicular lympho-
mas and also present in many diffuse lymphomas. It may 
be impossible to determine by routine histological tech-
niques whether normal small lymphocytes are part of the 
neoplastic proliferation or they are reactive or residual 
benign cells. The large number of T-cells in T-cell-rich 
B-cell lymphomas (TCRBCLs) has been regarded as an 
active reaction to the neoplastic B-cells.""') It is suggested 
that T-cell infiltration may be a passive response to cyto-
kine production by the tumor cells. 
  In this report, we described immunohistochemical fea-
tures of T-cell lymphocyte infiltration in 38 cases of NPC 
biopsy obtained from southern China, and also discussed 
mechanism of normal T-cell lymphocyte infiltration adja-
cent to neoplastic cells.
Materials and Methods 
The NPC specimens from 38 biopsy cases at the Jinan 
University Hospital in southern China were used. Shanmu-
garatnam and Sobin criteria were applied in assigning the 
diagnosis of NPC to the tissue. These NPC cases were 
divided into three groups as follows: (1) squamous cell 
carcinoma type, (2) differentiated non-keratinizing carci-
noma type, and (3) undifferentiated carcinoma type."' 
 The specimens were fixed in 10% formalin, and em-
bedded in paraffin for histological and immunohis-
tochemical studies. Sections were cut at 4 micron and 
stained with hematoxylin and eosin stain for histological 
examination. These specimens were stained by indirect 
peroxidase-antiperoxidase (PAP) method for B-cells 
(monoclonal antibody; Bio-science products; Switzerland; 
anti-leukocyte B-cells (MB-1); Lot. 050), T-cells (mono-
clonal antibody; Bio-science products; Switzerland; anti-
leukocyte T-cells (MT-1): Lot. 101), L26 (monoclonal 
antibody; Dako Corp., U. S. A., for identification of human 
B-cell lymphoma; CD20; Lot. 090), 4KB5 (monoclonal 
antibody; Dako corp., U. S. A., for identification of human 
B-cell; CD4SR; Lot. 109), leukocyte common antigen 
(LCA) (monoclonal antibody; Dako Corp., U. S. A., PAP 
kit 0535, Lot. 00098), S-100 protein (polyclonal antibody; 
Dako Corp., U. S. A., PAP kit K0524, Lot. 128-1), lyso-
zyme (polyclonal antibody; Dako Corp., U. S. A., PAP kit 
K504, Lat. 128-2), and alpha- l-antichymotrypsin (ACT) 
(polyclonal antibody; Dako Corp., U. S. A., PAP kit 
K0534, Lot. 078-2). LCA, S-100 protein, lysozyme, and 
ACT were not diluted. MB-1, and MT-1 were diluted 1:200 
with phosphate buffered saline (PBS) pH 7.4. L26, and 
4KB5 were diluted 1:50 with PBS pH 7.4. The indirect 
PAP method was performed for the staining of MB-1, 
MT-1, L26, and 4KB5 using Dako universal kit for mono-
clonal antibody (Dako Corp., PAP kit K0550, Lot. 128-2). 
 The steps involved in the immunoperoxidase procedure 
are as follows: (1) Deparaffinize and hydrate in distilled 
water. (2) Treat with hydrogen peroxidase for 5 minutes. 
(3) Wash in Tris buffer pH 7.4 using three cycle changes of 
3 minutes each. (4) Treat with normal serum for 20 
minutes. (5) Treat with tap off excess normal serum from 
sections. (6) Treat with primary antibody for 3 hours in 
room temperature. (7) Wash in Tris buffer pH 7.4 using 
three cycle changes of 5 minutes. (8) Treat with second 
antibody for 40 minutes in room temperature. (9) Wash in 
Tris buffer pH 7.4 using three cycle changes of 5 minutes. 
(10) Treat with PAP for 40 minutes in room temperature. 
(11) Wash in Tris buffer pH 7 4 using three cycle changes 
of 5 minutes. (12) Treat with 3, 3-diaminobenzidine tetra-
hydrochloride (DAB) solution with hydrogen peroxidase 
for 5 minutes. (13) Wash in running water. (14) Nuclei 
stain in Mayer's hematoxylin for 2 minutes. (15) Wash in 
running water. (16) Dehydrate, clear, and mount.
expression in the NPC associated with high content of 
reactive T lymphocytes were observed (Fig. 2). In the 
tumor nests, T-cell lymphocytes were detected in squamous 
cell carcinoma type (50%), differentiated non-keratinizing 
carcinoma type (72%), and undifferentiated carcinoma type 
(86%). Therefore, there was a rich infiltrate of mature T 
lymphocytes that comprised more than 70% of the cellular 
population. These infiltrated cells did not react with S-100 
protein, ACT, and lysozyme, thus, histiocytes and dendritic 
cells were not observed in NPC tissues.
Results 
The patients ranged in age from 21 to 80 years with a mean 
of 46 years. Twenty-six cases were males and 12 cases 
were females. These NPC were classified into three groups 
according to their predominant pattern with hematoxylin 
and eosin stain on the basis of light microscopy. The first 
group consisted of 6 cases of squamous cell carcinoma 
type. The second was made up of 25 cases of differentiated 
non-keratinizing carcinoma type, and the third included 7 
cases of undifferentiated carcinoma type. 
 All tumor tissues reacted with MB-1 (Fig. 1), but did not 
react with L26 (CD20), and 4KB5 (CD45R) as B-cell 
markers. These neoplastic tissues did not react with MT-1, 
and LCA. On the other hand, MB-1, MT-1, LCA, and 
4KB5 reacted with infiltration of lymphoid cells adjacent to 
tumor tissues. Thirty-eight cases of B-cell antigen marker
Fig. 1. Undifferentiated carcinoma type of nasopharyngeal carci-
noma cells strongly reacted with MB-1. A few infiltrate lympho-
cytes were stained by MB-1, thus, most of normal lymphocytes 
were showed T-cell nature. Immunoreaction for MB-1, X 200.
Fig. 2. Undifferentiated carcinoma type of nasopharyngeal carci-
noma cells did not reacted with MT-1. Most of infiltrate lympho-
cytes were stained with MT-1. Immunoreaction for MT-l, X 200.
Discussion 
Thirty-eight cases of NPC obtained from southern China 
were analyzed using immunohistochemical procedure em-
ploying various antibodies. All cases of NPC reacted with 
MB-1, thus, these cases were expressed as B-cell antigen 
marker in NPC tissues. The EBV is associated with a 
variety of benign and malignant lymphoproliferative disor-
ders, most notably infectious B-cell lymphoma and 
NPC."" The mechanism of MB-1 positive tumor cells is 
not clear. A possible explanation may be that NPC pro-
duces one of B-cell antigen, or NPC has similar epitope 
such as reacted with MB-1. Malignant tumors primarily 
arising in the nasopharynx are most often carcinoma or 
malignant lymphoma. Undifferentiated NPC is accom-
panied by prominent lymphocytic infiltration, thus, it is 
often difficult to differentiate from malignant lymphomas, 
especially of the large-cell type. NPC is a definite malig-
nant epithelial neoplasm and can be distinguished from 
malignant lymphoma by immunohistochemical staining for
keratin, EMA, and LCA " 13 `8) 
 The authors reported 38 cases of NPC which expressed 
B-cell antigen marker associated with abundant normal 
T-cell lymphocytes."' The mechanism of large number of 
normal T-cell lymphocytes detection in NPC is not clear, 
although, similar phenomenon is seen in TCRBCLs. In 
TCRBCLs, abundance of reactive T cells results in an 
appearance quite different from the classical descriptions of 
large B-cell lymphomas. TCRBCLs are not clearly desig-
nated in any non-Hodgkin's lymphoma classification. In 
the Kiel classification, most of the cases can be cassified 
cytologically as immunoblastic and centroblastic lym-
phoma. However, in the Working Formulation, it is uncer-
tain whether they should be classified as mixed, small- and 
large-cell lymphoma, large-cell immunoblastic lymphoma, 
or unclassifiable lymphoma. TCRBCL cases resemble 
peripheral T-cell lymphomas (PTCLs), and are easily con-
fused with PTCLs. Flow cytometry and frozen section 
immunoperoxidase methods in TCRBCLs may support the 
misdiagnosis of PTCL, because the large number of reac-
tive T-cells may obscure the small B-cell population." The 
exclusive use of frozen sections for immunohistochemistry 
increases the risk of such error, because morphological 
detail is poorly preserved and small neoplastic population 
may be hidden by large numbers of reactive T-cells, al-
though, these disadvantages are avoided in paraffin sec-
tions. The B-cell nature of TCRBCLs is most readily 
recognized by paraffin immunohistochemistry of L26 
which react with normal and neoplastic B-cell specificity of 
this new antibody." The role of large number of T-cell 
lymphocytes in NPC is not clear. The possible explanation 
is that normal T-cell lymphocyte infiltration may be passive 
to cytokine secretion by the neoplastic cells. Therefore, 
morphological features of large number of T-cell lympho-
cytes present positive diagnosis of B-cell marker expressed 
neoplasms.
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